F
Forte Biosciences, Inc. Common StockFBRX
Forte Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing FB102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related.
US StocksHealthcareSmall CapBiotechnology
FBRX 가격 추세
Forte Biosciences, Inc. Common Stock · TradingView 전체 차트
NASDAQ:FBRX